Aclaris Therapeutics, Inc. (ACRS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 369.22M |
| Enterprise Value | 351.38M |
| P/E Ratio | -8.04 |
| PEG Ratio | -0.15 |
| Price/Sales Ratio | 64.86 |
| Price/Book Ratio | 4.04 |
| Enterprise/Revenue | 61.67 |
| Enterprise/EBITDA | -7.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -8.33 |
| Operating Margin | -9.62 |
| Return On Assets | -0.35 |
| Return On Equity | -0.56 |
| Revenue | 7.83M |
| Revenue/Share | 0.06 |
| Gross Profit | 5.74M |
| EBITDA | -64.47M |
| Net Income | -64.92M |
| Diluted EPS | -0.53 |
| Total Cash | 105.42M |
| Total Cash/Share | 0.82 |
| Total Debt | 1.99M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4.03 |
| Book Value Per Share | 1.12 |
| 52-Week Change | 223.74 |
| 52-Week High | 5.15 |
| 52-Week Low | 1.34 |
| Moving Average 50 Days | 4.44 |
| Moving Average 200 Days | 3.24 |
| Average Volume | 1.43M |
| Shares Outstanding | 120.6M |
| % Held by Institutions | 88.63 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |